- Report
- March 2024
- 194 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- May 2023
- 170 Pages
Global
From €5779EUR$5,950USD£4,985GBP
- Report
- February 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- April 2024
- 180 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2023
- 190 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- January 2020
- 156 Pages
North America
From €4808EUR$4,950USD£4,147GBP
- Report
- December 2023
- 120 Pages
Canada
From €5779EUR$5,950USD£4,985GBP
- Report
- December 2022
- 100 Pages
Global
From €2671EUR$2,750USD£2,304GBP
- Report
- January 2022
- 120 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- April 2024
- 50 Pages
Global
From €2574EUR$2,650USD£2,220GBP
Iodine-125 is a radioactive isotope of iodine used in Nuclear Medicine and Radiopharmacology. It is used in the diagnosis and treatment of various diseases, including thyroid cancer, prostate cancer, and brain tumors. It is also used in the production of radiopharmaceuticals, which are used to diagnose and treat a variety of medical conditions. Iodine-125 is produced in nuclear reactors and cyclotrons, and is available in a variety of forms, including capsules, solutions, and solid forms.
Iodine-125 is used in a variety of medical applications, including imaging, radiation therapy, and radiopharmaceuticals. It is also used in research and development, and in the production of medical devices.
Companies in the Iodine-125 market include Nordion, Inc., Lantheus Medical Imaging, Inc., and Jubilant Pharma. Show Less Read more
